A booster dose of the vaccine COVID-19 of Johnson & Johnson is 85% effective against being treated by the Omicron variant of the new coronavirus for 1-2 months after its administration, the head of the South African Medical Research Council (SAMRC) said today.
Glenda Gray presented the findings of the SAMRC investigation in a briefing to reporters by the South African Ministry of Health on the fourth wave of the new coronavirus epidemic in the country, which was caused by the new Omicron variant.
"We saw 85% efficacy of the vaccine and we saw that this kind of efficacy of the vaccine is maintained for up to two months," he noted.
"We are very happy to report very high levels of efficacy of the vaccine against Omicron," he said.
The study looked at health care affected during the fourth wave of the epidemic in the country and found that the booster dose reduced treatment by 63% in the first two weeks after administration, reaching 85% thereafter for between one and two months.
in.gr